Interleukin-23 Inhibitors: Advancing Targeted Therapies for...

Ajouter une nouvelle offre d'emploi Health

2025-11-18 11:21:20

Interleukin-23 Inhibitors: Advancing Targeted Therapies for Autoimmune Disorders

Interleukin-23 (IL-23) has become a central cytokine in the development of various autoimmune and inflammatory diseases. In recent years, the Interleukin-23 Inhibitor Pipeline has revolutionized treatment approaches for conditions such as psoriasis, psoriatic arthritis, and inflammatory bowel disease. These biologic therapies specifically inhibit IL-23, a key mediator in the Th17 immune...

0 Commentaires 0 Parts 46 Vue 0 Aperçu